Basic Materials / Specialty ChemicalsNasdaqGM
$8.06
+0.06 (+0.75%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 25%
FCF escenarios
weak_data · normalized FCF $2.2M · quality 44.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
35/100
D
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$77M
P/E
N/A
•EV/EBITDA
15.5x
↑ROE
0.0%
↑Gross Margin
37.6%
↑Debt/Equity
0.18
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2011–2025 · 14 años de histórico normalizado
Revenue CAGR
+11.0%
FCF CAGR
—
FCF margin
-1.8%
FCF / Net income
-85.55x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $84.2M · net income $17619.0 · FCF $-1.5M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||||||
| Revenue | $84.2M | $84.2M | $85.1M | $79.9M | $74.2M | $56.5M | $47.6M | $55.8M | $51.4M | $39.6M | $32.9M | $30.3M | $6.3M | $5.3M | $22.8M | $19.5M |
| Net Income | $17619.00 | $17619.00 | $5.4M | $2.9M | $6.3M | $6.3M | $-1.3M | $5.2M | $6.7M | $3.4M | $-867514.00 | $1.8M | $858586.00 | $389622.00 | $3.4M | $3.9M |
| EBITDA | $5.4M | $5.4M | $9.7M | $7.7M | $10.7M | — | — | — | — | — | — | — | — | — | — | — |
| EPS | — | — | 0.55 | 0.30 | 0.66 | 0.64 | -0.15 | 0.55 | 0.72 | 0.38 | -0.10 | 0.19 | 0.10 | 0.04 | 0.39 | 0.45 |
| Gross Margin | 37.6% | 37.6% | 39.7% | 34.8% | 31.1% | 34.6% | 33.6% | 31.9% | 33.6% | 33.5% | 32.2% | 32.2% | 34.1% | 30.3% | 36.2% | 34.6% |
| Operating Margin | -7.1% | -7.1% | -1.9% | -7.0% | -7.2% | 14.7% | 3.3% | 11.8% | 15.6% | 11.6% | 3.9% | 10.4% | — | — | 20.1% | 23.7% |
| Net Margin | 0.0% | 0.0% | 6.4% | 3.6% | 8.5% | 11.1% | -2.8% | 9.3% | 13.0% | 8.6% | -2.6% | 5.9% | 13.6% | 7.4% | 15.1% | 20.0% |
| Balance Sheet | ||||||||||||||||
| Debt/Equity | 0.18 | 0.18 | 0.11 | 0.10 | 0.10 | — | — | — | — | — | — | — | — | — | — | — |
| Current Ratio | 1.81 | 1.81 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Cash Flow | ||||||||||||||||
| Free Cash Flow | $-1.5M | $-1.5M | $2.5M | $2.2M | $-557745.00 | $-2.6M | $4.2M | $4.5M | $-71815.00 | $4.8M | $1.4M | — | — | — | $-1.4M | $-1.7M |
| Returns | ||||||||||||||||
| ROE | 0.0% | 0.0% | 7.6% | 4.4% | 9.9% | 10.1% | -2.4% | 9.2% | 12.6% | 7.0% | -1.9% | 4.0% | — | — | 9.4% | 11.3% |
| Valuation | ||||||||||||||||
| P/E | — | — | 22.73 | 44.70 | 17.47 | — | — | — | — | — | — | — | — | — | — | — |
| EV/EBITDA | 15.51 | 15.51 | 12.88 | 17.11 | 10.47 | — | — | — | — | — | — | — | — | — | — | — |
| P/B | 1.08 | 1.08 | 1.73 | 1.96 | 1.75 | — | — | — | — | — | — | — | — | — | — | — |
| Growth & Yield | ||||||||||||||||
| Revenue Growth | -1.0% | -1.0% | 6.5% | 7.7% | — | 18.6% | -14.5% | 8.4% | 30.0% | 20.1% | 8.6% | 380.6% | 19.2% | -76.8% | 16.7% | — |
| EPS Growth | — | — | 83.3% | -54.5% | — | 526.7% | -127.3% | -23.6% | 92.0% | 494.7% | -150.0% | 100.0% | 111.1% | -88.5% | -12.4% | — |
| Dividend Yield | 0.5% | 0.5% | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+12.0%
Start / end P/E
n/dx → n/dx
EPS bridge
0.55 → n/d
Residual
+11.5%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.